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BACKGROUND: Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal 
muscle mass and strength. It imposes significant costs on health care systems. Socioeconomic status is 
also the root cause of healthy challenges among the elderly. Therefore, investigating the association 
between sarcopenia and socioeconomic status is very important to improve healthy ageing of the elderly. 
The aim of this study was to investigate the prevalence of sarcopenia and its association with 
socioeconomic status among the elderly in Tehran. 
METHODS: Cross-sectional and case-control studies were conducted from August 2014−July 2015 
among 310 men and 334 women elderly (60 and over years old) in Tehran health centers. 
Randomization, restriction and matching were setting during study design  to minimize selection bias. 
Then study participants were recruited via phone call. Participants’ phone numbers were already 
recorded in a telephone book electronically. When there were two elderly people in the same house, only 
one person was invited randomly. Association between sarcopenia and socio-economic status was 
analyzed by SPSS version 22. 
RESULTS: The overall prevalence of sarcopenia in the elderly was 16.5%. Prevalenceamong the low-
income elderly was relatively higher than (20.5%) that among those with middle income status (18.2%) 
while in the higher income, the proportion of sarcopenia was very low (12.8%). The findings indicated 
that 339(52.6%) were in low-income status, 304(47.1%) were in middle-income status and 1(.2%) in 
high-income class.  
CONCLUSION: There was a significant association between socioeconomic status and sarcopenia (P-
value <0.001). The odd risk of sarcopenia was 0.97 times more likely higher in low socioeconomic class 
than those who were in middle and high income classes. 
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Sarcopenia is a syndrome characterised by 
progressive and generalised loss of skeletal muscle 
mass and strength with a risk of adverse outcomes 
such as physical disability, poor quality of life and 
death (1,2). It was first coined as “sarcopenia” by 
Irwin Rosenberg (3,4) in 1998. More recently, on 
the third updated published article, in 2014, the 
European Working Group on Sarcopenia 
(EWGSOP) again recognized that the key element 
is a loss of muscle strength (dynapenia) rather than 
a loss of muscle mass (5). This has led to a change 
in the definition of sarcopenia to include strength 
(grip strength) or function (walking speed or 
distance). Now, sarcopenia is defined as a decline 
in walking speed or grip strength associated with 
low muscle mass. Based on this concept, a number 
of societies around the world have provided 
revised definitions of sarcopenia (6-11). These 
definitions have to some extent deemphasized the 
importance of aging, recognizing that sarcopenia 
has a variety of causes in addition to physiological 
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effects of aging (11).  
Sarcopenia imposes significant costs on 
health care systems. In the United States alone, 
sarcopenia-related costs were estimated to be more 
than $18.5 billion in 2000 (12). Sarcopenia is 
considered to be the underlying cause of frailty 
(13), which is in turn the sixth cause of death 
among people over 65 years old. It also increases 
the risk of falling and disability among the elderly 
(13). The modifiable behavioral factors such as 
physical activity level, androgen hormone level 
(14), smoking habits and, particularly, the quality 
and quantity of dietary intake (15) can be 
important in delaying or even preventing 
sarcopenia. In addition, socioeconomic status is 
the root cause of health issues among the elderly 
(16). There are obvious differences between 
income and economic status and health (17). 
There are also obvious disparities between the 
health statuses of the elderly (18). Many studies 
have investigated the association between 
nutritient intake such as protein (19-26), vitamins 
(27,28), minerals (29) and antioxidants (30) and 
sarcopenia. Our study is a first one in the world 
which has investigated the association between 
sarcopenia and socioeconomic status among 
theelderly. The aim of this study is to assess the 
association between the prevalence of sarcopenia 
and socioeconomic status and among the elderly 
in Tehran.  
 
METHODS AND MATERIALS 
 
Study design: A study of cross-sectional that 
began in August 2014 with a probabilistic 
sampling followed by a case-control study 
among 644 elderly aged 60 years and older 
living in the southern part of the Tehran till 
July 2015 for 13 months. The socio-
demographic characteristics included age, 
gender, marital status; income and schooling 
were collected through self report. Age was 
grouped in three 10-year categories, with all 
those aged 80 years or older combined into 
one group. Marital status was classified as 
married (married or in a stable relationship) or 
not married/single (divorced, separated or 
widowed). Schooling (in years) was analyzed 
as a continuous variable.Sampling technique: 
A pilot study was conducted to validate the 
procedures at first. We then identified sarcopenic 
cases among the elderly in the first phase of the 
study (cross-sectional). Next, sarcopenia cases 
were assigned for second phase of study (case-
control) to compare outcomes with socioeconomic 
status. Each socioeconomic data was first 
prearranged, categorical and examined alone in 
order to measure its outcomes with the proportion 
of the sarcopenia. Group matching was done 
instead of individual matching by their age, sex 
and place of residence (ratio was 1:2). Hence, it 
was very difficult both in time and financial going 
to find out an accurate listing of all theoretical 
elderly population in Iran,we should make a 
difference between the population, we would like 
to study to, and it was the accessible elderly 
population in Tehran.The theoretical elderly 
population in Iran was 6,162,273 (census 2011) 
while accessible elderly in Tehran was 
approximately 668,300 (calculated from 2011 
census.Then we had randomely selected 
southern part of Tehran and invited people 
who able to come to public health centers 
under the patronage of Tehran University of 
Medical Sciences. This about one third of 
public health centers (10/31) located in 
southern of Tehran. Then through sampling 
frame which was “electronic telephone books 
address” we had randomely picked their phone 
number and invited them to the centers. The 
participants’ phone numbers were already 
recorded on telephone book/registration book at 
the nearby health center. Then, the study 
participants were recruited via  phone call to come 
to the nearby cluster. When there were two 
eligible elderly people (husband and wife) in a 
household, only one person was invited randomly 
to participate in the study. In the case of no 
eligible person in the selected household, the 
interviewer would take the next phone call. By 
doing so, finally, we drew our sample, 644 elderly 
people from 6 Districts in Tehran, using simple 
random sampling procedure in the 6 clustered 
health centers. The sample size was determined 
using single proportion formula for cross-sectional 
studies while in case-control, it was determined by 
comparing two population estimation P1 and P2 
(given a 95% confidence level and 80% power). 
To minimize bias, errors and possible confounding 




factors, we randomized, restricted and matched 
ubjects during study design and data collection. 
Missing data were checked and controlled by 
running descriptive frequencies and excluding 
case pairwise. Therefore, there were no missing 
data identified during data analysis. 
 
Instruments: Standard questionnaire was used to 
collect data on income, occupation, education 
level and health status. To collect socioeconomic 
data, we used self-report and “household 
economic based indicators” which include seven 
items such as a flat television, fridge, carpenter, 
house, car, laptop and sofa.  This questionnaire 
was taken from the previous a study and 
standardized in the Iranian context. This 
questionnaire contains a series of questions about 
information on a wide range of qualifications 
including vocational qualifications gained at work 
place and other household durables or facilities. 
Respondents that lacked an amenity were asked 
the reason for not having it. Respondents who 
answered more than 6 questions and over were 
considered as a high income status while those 
who ticked between 3-5 questions were considered 
as middle income class and those who answered 1-
2 taken as low-income status.  
Muscle mass data were taken, measured and 
calculated from  anthropometric variables such as 
height, hip, waist, wrist, ankle, knee, arm, thigh, 
upper and median (in meter) and then were 
entered into the software and analyzed by 
Bioimpedance analysis (BIA). Other 
measurements such as weight (in Kg) and body 
mass index were calculated and entered into the 
same software. Handgrip strength was measured 
with maximum voluntary contractions for each 
participant by squeeze bulb dynamometer (c7489-
02). We would repeat the measurement three times 
for each hand with a 30-second rest time in 
between each trial. Physical performance was 
measured by doing a 6-meter course gait speed 
test. Each participant was asked to walk at his/her 
usual pace to the other end of the 6-meter course. 
Time was recorded by chronometer in seconds. 
The cutoff points for each of them were obtained 
from the previous study. Muscle mass less than 
8.87 kg/m
2
 for men and 6.42 kg/m
2
 for women 
was considered as abnormal (2, 31-34),  while 
handgrip strength <30kg for men and <20kg for 
women was taken as abnormal (1) and gait speed 
<0.8m/s was abnormal for both genders (35-37). 
We used EWGSOP definition of sarcopenia to 
define the case group. According to this definition, 
individuals with abnormal muscle mass or 
abnormal hand grip strength, or weak physical 
performance were considered as pre-sarcopenic 
while  sarcopenic person was an individual who 
abnormal was with two variables together (muscle 
mass and hand grip strength or muscle mass and 
physical performance or hand grip and physical 
performance). Those with all the three abnormal 
criteria were considered as the severely sarcopenic 
(4). The relationship between sarcopenia and 
socioeconomic status were analyzed by SPSS 
software. 
 
Subjects: A total of 644 individuals participated 
in this study, out of whom 310(41.1%) and 
334(51.9%) were elderly males and females 
respectively. 
Inclusion criteria:  
 Participants had to be 60 years and above. 
 Participants had to be able move without 
crutches, walker or other assistive devices. 
 There had to be an absence of artificial limbs 
or limb prosthesis. 
 There had to be an absence of active cancer, 
according to individual self report. 




Pre-coded data were entered into the computer and 
cleaned through the phase-by-phase screening 
using SPSS version 22.0 software for analysis. 
Multiple analyses such as crosstab, bivariate, 
independent-sample t-test and logistic regression 
were used. Frequency, proportion and summary 
statistics were used to describe the characteristics 
of the study population. Ten percent (10%) of the 
total data were randomly selected and cross- 
checked for reliability respective to the original 
data. The odds ratio and 95% CI were computed to 
see the presence and degree of association 
between scorpion and socioeconomic status. P-
value < 0.05 was considered as statistically 
significant, and multivariate logistic regression 
was employed to control possible confounding 
factors.   
 
Ethical issues: The Ethics Committee and Vice 
Chancellor for Research at Tehran University of 
Medical Sciences approved the project in 
accordance with the tenets of the Helsinki 





Declaration and the national ethical guideline for 
medical research. The ethical approval code is 
IR.TUMS.REC.1394.346. Furthermore, informed 
consent was obtained from the study participants 




Table 1 shows general demographic 
characteristics of the study participants. A total of 
644 individuals participated in this research study, 
out of whom 310(41.1%) and 334(51.9%) were 
elderly males and females respectively. The mean 
age of the participants was  (70.8 ± 6.1). There 
was no case of dropout throughout the study and 
so the response rate was 100%. The findings of 
our study indicated that 339(52.6%) were in low-
income status, 304 (47.1%) were in middle 
income status and 1(.2%) in high income class. 
Using Asian Working Group and European 
Working Group, the prevalence of sarcopenia was 
found to be 16.5% and 32.5% respectively. 
Prevalence of pre-sarcopenia was (21.2%). Severe 
sarcopenia was not reported during the data 
collection period. Prevalence of sarcopenia was 
27.1% and 6.6% among men and women 
respectively. In crosstab analysis, proportion of 
pre-sarcopenia and sarcopenia in low-income were 
a relatively higher than (22.6% and 20.5%) in 
those with middle income (21.7 and 18.2%) while, 
in the higher income, the proportions of pre-
sarcopenia and sarcopenia were lower (13.7 and 
12.8%). Educational level, occupation, and 
income status largely contributed to the 
development of sarcopenia among the study 
participants. For instance, proportion of 
sarcopenia in an illiterate, primary school and 
diploma+ were 18.6%, 16.2%, and 12.3% 
respectively. For those who had occupations, the 
proportion of sarcopenia was smaller (16.4%), 
while, for those who had no occupation, the 













Mean ± Standard 
deviation 
Age: (70.8 ± 6.1) years 
Sex: 
 Male 310(41.1%) 
Female 334(51.9) 
Marital status: 




BMI (kg/m2) 31.1±4.7 
Educational level: 
 Illiterate 296(46.0%) 
Primary school 210(32.6%) 
Secondary high school 42(6.5%) 
Diploma, BSC, MSC, 
MD 42(6.5%) 
Occupation: 
 Yes 4(.6%) 
      no 640(99.4%) 
 
Our findings indicated a significant association 
between sarcopenia and socioeconomic status (p-
value < 0.01). The relationship between 
socioeconomic status with sarcopenic and the non 
- scorpion was also investigated using Pearson 
product-moment correlation coefficient. 
Preliminary analysis was conducted to ensure no 
violation of the hypothesis of normality, linearity, 
and homoscedasticity. The same results were also 
observed with crosstab analysis that correlation 
between socioeconomic status and sarcopenia was 
significant (or = 1, N = 644, P-value <0.001). An 
independent-samples t-test was also performed to 
study the association between sarcopenic mean 
scores and socioeconomic status in sarcopenia. 
The mean score for sarcopenic cases was (1.5±.73) 
while the mean score for non-sarcopenic group 
was (1.60±.67); t (642) = 1.79, P-value = 0.02, 
two-tailed). The magnitude of the differences in 
the means (mean difference =0.1, 95%Cl: .1 -.2) 
was very small (eta squared = 0.004). The odd risk 
was calculated from the hypothetical data in table1 




estimated that sarcopenia risk was 0.97 times more 
likely to develop in those who were in lower 
socioeconomic status than those who were in 
middle income class. The number of high income 
status was negligible. Binary logistic regression 
was also performed to assess the odd risk of 
sarcopenia among the low, middle and high 
income elderly. The model contains five 
independent variables (sex, age, educational level, 
occupation, and socioeconomic status). 
Unadjusted estimates in the model I showed the 
odd risk of gender was 0.21, and statistically 
significant association was observed (P-value 
<0.001, with 95%CI = 0.44-1.07. All other 
variables were equal.  
 
Table 2. Cross tabulation of socioeconomic & Sarcopenic group among elderly in Tehran, Iran 2016 (N 
=644) 
 
  Low income Middle & high income Total 
Sarcopenic 40 180 220 
Non-sarcopenic 66 458 524 
Total 106 538 644 
OR 40*458 =  0.97 
   66*180     
*The odd risk of sarcopenia in low socio-economic class was .97 times higher than those in middle and high income 
class 
 
Table 3: Prevalence of sarcopenia based on different diagnostic criteria 
 
Criteria    Prevalence (%) 
European Working Group on Sarcopenia (EWGSOP) 207(32.5) 
Asian Working Group for Sarcopenia (AWGS) 106(16.5) 




The findings of this study indicated that the 
prevalence of sarcopenia was 16.5 and 32.5%, 
respectively using different definitions of 
AWGOS and EWGOS (Table 3). Males had 
21.3% sarcopenic cases compared to 8.9% in 
females. This result is found to be higher than a 
similar study conducted in the USA, in Taiwan 
and in Hong Kong, which showed the prevalence 
of sarcopenia as 26.8% (32), 23.6% (38) and 
12.3% (39) respectively. Unlike a similar study 
conducted in New Mexico, which indicated the 
prevalence of sarcopenia in male elderly to be 
50% (40) and 52% among male elders in the USA 
(41), in the present finding, sarcopenia is found to 
be less prevalent. In a study conducted in Taiwan, 
the prevalence of sarcopenia was reported as 
18.6% in elderly women and 23.6 in erderly men 
(36), while in our study, the prevalence of 
sarcopenia was 8.9% in elderly women  and 
21.3% in elderly men. This shows that the 
prevalence in elderly women was higher than our 
finding in elderly women and relatively in line 
with elderly men. According to a study conducted 
by the European Working Group on Sarcopenia 
(EWGSOP), the prevalence of sarcopenia in 
elderly females living in community-dwelling and 
men living in long-term care institutions were 
30% and 68% respectively (42,43), while our 
findings showed substantially lower proportion of 
sarcopenia in both males and females (21.3% and 
8.9%). On the other hand, a separate study was 
conducted in Geriatric hospitalized patients in J 
Am Med Dir Association, USA, and community-
dwelling persons in Italy who had low muscle 
mass which indicated that the percentage of 
sarcopenia scores among the elderly population 
were 25% and 20% (42,43). This finding is higher 
than the prevalence of our finding which is 32.5%. 
This study is found to be the first one in the gobe 
to study the association between sarcopenia and 





socioeconomic status among elderly people. Our 
results indicated that in low-income people, the 
prevalence of pre-sarcopenia and sarcopenia were 
higher (22.6% and 20.5%) than those middle 
income (21.7 and 18.2%). In higher income 
elderly  the prevalence of presarcopenia and 
sarcopenia was very lowe (13.7 and 12.8%) as 
compare to low and middle income people. 
Therefore, as people become poor, the chance of 
developing sarcopenia is gets high. Also, the 
findings show that educational level, occupation 
and income status are the main contributors in 
developing sarcopenia among study participants. 
For instance, the proportions of sarcopenia in the 
uneducated, primary schoolers and diploma 
holders and those who had above diploma were 
18.6%, 16.2%, and 12.3% respectively. In the 
meantime, having an occupation and good income 
also played a great role in the development of 
sarcopenia. Moreover, the findings indicated that 
the proportion of sarcopenia in elderly people who 
did not ave any occupation (25%) was higher than 
those who had occupations (16.4%). In addition, 
the results of the study indicated that the mean 
scores of  sarcopenic people  were a bit higher 
among people with  middle and high income status 
when comparing to non-sarcopenic elderly people 
(1.60 ±0.67) and for non-sarcopenic (1.5±0.73), 
t(642) = 1.79, p-value = 0.02, two-tailed). The 
findings revealed that in low-income elderly, the 
chance of developing sarcopenia was higher with 
an odd risk of 0.97 in low income and 0.8 for both 
middle and high income elderly persons. These 
indicate that elderly people who are in low-income 
status are 0.97 times more likely to develop 
sarcopenia than those who are in middle or high 
income status. As mentioned before, this study is 
the first one in the world to investigate the 
association between scorpenia and socioeconomic 
status in elderly people. This makes it difficult to 
compare our results with another study. On the 
other hand, a pilot study was conducted before 
commencement the main study to validate the 
scale’s reliability and validity. Daily field 
supervision and data checking took place as a 
follow-up method. We concluded that there is a 
significant association between sarcopenia and 
socioeconomic status. Elderly people with lower 
socioeconomic status are more likely to develop 
sarcopenia (p-value < .01). Therefore, elderly with 
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